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Abstract
Background: The literature recognizes a need for greater patient involvement in health technology assessment (HTA),
but few studies have been reported, especially at the local level. Following the decentralisation of HTA in Quebec,
Canada, the last few years have seen the creation of HTA units in many Quebec university hospital centres. These units
represent a unique opportunity for increased patient involvement in HTA at the local level. Our project will engage
patients in an assessment being carried out by a local HTA team to assess alternatives to isolation and restraint for
hospitalized or institutionalized adults. Our objectives are to: 1) validate a reference framework for exploring the
relevance and applicability of various models of patient involvement in HTA, 2) implement strategies that involve
patients (including close relatives and representatives) at different stages of the HTA process, 3) evaluate intervention
processes, and 4) explore the impact of these interventions on a) the applicability and acceptability of
recommendations arising from the assessment, b) patient satisfaction, and c) the sustainability of this approach in HTA.
Methods: For Objective 1, we will conduct individual interviews with various stakeholders affected by the use of
alternatives to isolation and restraint for hospitalized or institutionalized adults. For Objective 2, we will implement
three specific strategies for patient involvement in HTA: a) direct participation in the HTA process, b) consultation
of patients or their close relatives through data collection, and c) patient involvement in the dissemination of HTA
results. For Objectives 3 and 4, we will evaluate the intervention processes and the impact of patient involvement
strategies on the recommendations arising from the HTA and the understanding of the ethical and social
implications of the HTA.
Discussion: This project is likely to influence future HTA practices because it directly targets knowledge users’ need
for strategies that increase patient involvement in HTA. By documenting the processes and outcomes of these
involvement strategies, the project will contribute to the knowledge base related to patient involvement in HTA.
Keywords: Health technology assessment, patient involvement, decision making, knowledge users, alternatives to
isolation and restraint
Background
The purpose of health technology assessment (HTA) is
to summarize information about the clinical, economic,
psychological, social and ethical aspects of health tech-
nologies (e.g. prevention programs, drugs, medical
devices, procedures or systems used in screening,
diagnosis, treatment, rehabilitation or palliation) in
order to inform decisions about the introduction or use
of these technologies [1]. To date, however, most HTA
activities have focused on the clinical effectiveness and
cost effectiveness of health technologies to the detriment
of the other dimensions [2-4], such as their social and
ethical aspects and the patient perspective, both of
which are emphasized as important in the literature
[5-11]. As direct beneficiaries of the technologies,
patients have concrete knowledge of the impact and
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any medium, provided the original work is properly cited.effects of treatments and technologies on their condition
and on other areas of their lives [1]. Taking their per-
spective into account is therefore essential in order to
arrive at a more complete assessment of the real value
of health technologies and of their impact on the health
of populations [7].
Policy makers, managers and HTA producers are thus
increasingly interested in exploring strategies for incor-
porating the patient perspective in HTA activities [6,12].
A systematic review of the literature [13] assessing inter-
national studies in the area of patient and public invol-
vement in HTA led us to observe that despite all the
theoretical benefits commonly associated with involving
patients and the public in HTA, there is little evidence
to support these benefits. In fact, in the scientific litera-
ture [13], there are very few empirical evaluations of
patient or public involvement in HTA. This lack of doc-
umentation may be due to the fact that patient involve-
ment is seen more as an end in itself, rather than a
means, and to the difficulty of evaluating their involve-
ment without the support of widely accepted frame-
works and tools [14].
Nonetheless, this systematic review identified 24 stu-
dies showing different means of integrating the patient
perspective in assessing technologies or specific methods
of dispensing and organizing services. Various experi-
ences of patient consultation in HTA, such as the defi-
nition of schizophrenia treatment outcomes relevant to
patients [15] or the analysis of the impact of pressure
ulcers on quality of life [16], have been conducted by
collecting primary research data. Some of these studies
report that focusing on the patient perspective raises
important issues, so far ignored, related to the use of
assessed technologies. For instance, a study by Kinter
[15] has shown that some of the criteria deemed essen-
tial by schizophrenic patients concerning their medical
treatment (such as the ability to think clearly, participate
in social activities, etc.) did not coincide with traditional
clinical criteria used in the assessment of this treatment.
Other studies listed in this review evaluated the direct
participation of patients in HTA activities, notably those
conducted by the National Institute for Health and Clin-
ical Excellence (NICE), and the National Coordinating
Centre for HTA (NCCHTA) in the United Kingdom
[17-20]. These studies highlighted several elements of
successful patient participation experiences, such as ade-
quate preparation of participants, clear presentation of
the topic of the meeting, and recruitment of people
affected by the health technology assessed. Some bar-
riers are also identified, such as problems related to
recruitment, time, patient skills and their ability to parti-
cipate, as well as the cultural differences among com-
mittee participants.
Moreover, our exploration of HTA stakeholders’ views
and practices during interviews conducted in a previous
project revealed that there is agreement on the relevance
of considering patient perspectives in HTA even though
few experiments have yet been conducted at the local
level (Gagnon et al., unpublished data). According to
stakeholders, two methods were usually deemed relevant
to seek the patient perspective in HTA: a) consulting
patients or their close relatives as part of data collection,
when the type of technology and issues assessed were
appropriate for that, for example, when they have a
great potential impact on patient’s quality of life, and b)
directly involving patient representatives in the assess-
ment process, particularly during the three stages of:
developing the assessment plan (or protocol), discussing
the assessment report and recommendations, and disse-
minating results (Gagnon et al., unpublished data).
These interviews enabled us to identify the main fac-
tors facilitating or impeding each type of involvement
according to the different stakeholders. We were thus
able to outline the main elements of a reference frame-
work for patient participation in HTA at the local level,
an outline which forms the basis of this project.
This research project will complement a project prior-
itized by the Sectorial Table on HTA at the Réseau uni-
versitaire intégré de santé de l’Université Laval (RUIS-
UL) in Quebec, Canada. After collecting information
from member institutions in 2009, this sectorial table
selected a question with supra-regional scope for HTA,
namely, alternatives to isolation and restraint for hospi-
talized or institutionalized adults. The HTA unit at the
Centre hospitalier universitaire de Québec (CHUQ) was
mandated to carry out the assessment.
The aim of this research project is to use our frame-
work to implement and then evaluate interventions
involving patients in the assessment of alternatives to
isolation and restraint for hospitalized or institutiona-
lized adults.
Research question and objectives
This research aims to answer the following questions:
What are the impacts of targeted interventions to pro-
mote patient involvement in HTA activities, and how
effective are they?
The objectives of this project are:
1) To validate the reference framework developed in
our previous project and to explore the relevance and
applicability of different models of patient involvement
in the specific context of assessing alternatives to isola-
tion and restraint for hospitalized adults or elderly peo-
ple in nursing homes.
2) To implement interventions involving patients
(including close relatives and representatives) at
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also in the dissemination of its results.
3) To evaluate the intervention processes to further
understand the contextual issues (ethical, social and
organisational) of patient involvement in HTA activities.
4) To explore the impacts of these interventions on: a)
the applicability and acceptability of recommendations
arising from the assessment from the patients’ perspec-
tive and that of the other groups involved in HTA; b)
patient satisfaction; and c) the sustainability of this
approach in HTA activities.
Methods and design
This research project was designed with the collabora-
tion of the HTA unit at the Quebec University Hospital
Centre (Centre hospitalier universitaire de Québec -
CHUQ) and its partners. We adopt an action research
strategy which allows for constant adjustments between
research objectives, methods, data collection, and analy-
sis. The various activities we will undertake to achieve
each objective of the study are described in the follow-
ing section.
Objective 1
Validate the reference framework and explore the relevance
and applicability of patient involvement models
To achieve this objective, individual interviews will be
conducted with representatives of the regional health
agencies targeted by the project, with members of health
and social services centres (CSSS) and HTA organisa-
tions, and with representatives of patient associations
affected by the use of alternatives to isolation and
restraint for hospitalized or institutionalized adults. We
expect to carry out about 20 interviews in the entire
area served by the RUIS-UL. An interview guide will
cover questions on the applicability and relevance of the
different models of patient involvement in the HTA of
alternatives to isolation and restraint for hospitalized
adults or elderly people in nursing homes. Interviews
will be recorded digitally following informed consent of
participants. The content of the interviews will be tran-
scribed verbatim and analysed using N*Vivo software
[21].
A thematic analysis of the content will be carried out
using a three steps method described by Huberman and
Miles [22]: data reduction, data display, and drawing
conclusions/verification. To ensure the internal validity
of the analysis process, interview codification will be
carried out independently by two members of the team
who have long experience in qualitative research using
an iterative approach. The results will be then pooled
and a consensus sought among the researchers with
regards the final codification. Validating our reference
framework this way is likely to result in the most
appropriate strategies, methods and tools in the context
of current practice in HTA, and will therefore have the
most potential for sustainability.
Objective 2
Development of interventions aimed at improving the
participation of patients in HTA
Overall, four stages of the HTA process can be
described [23] and subdivided into several sub-stages.
The first is the selection of the technologies to be
assessed and includes identifying and prioritizing the
assessment topics. The second is conducting the assess-
ment, including the following steps: development of the
protocol (or assessment plan), review of the evidence-
based data, contextualization of the data and a field
assessment if relevant, analysis and synthesis of the
results. The third stage is the production of a final
report which may include recommendations, and the
last stage of the HTA process is the dissemination and
implementation of the results.
According to our systematic review, patient or public
involvement is possible at each of these stages [13].
However, interviews conducted during the previous pro-
ject enabled us to identify certain steps (corresponding
to different sub-stages) that are particularly pertinent for
patient involvement. These steps are: a) the develop-
ment of the assessment plan (which allows patients’
views and concerns to be considered in analysing the
issues), b) the assessment itself (through consultation to
collect data from patients about their experiences, per-
ceptions and views), c) the discussion of the final report
and recommendations, and d) the dissemination of the
results [13]. Different modes of patient involvement
(that correspond to different levels of involvement) may
be used at these different steps [24] (see Additional File
1), mainly consultation - i.e data collection from patients
- and direct participation of patients in the committees
or working groups set up for a specific assessment.
Our project aims to implement and evaluate three
strategies of patient involvement in the HTA process
(See Additional File 1): 1) the direct participation of
patient representatives in the HTA process of assessing
alternatives to isolation and restraint for hospitalized or
institutionalized adults; 2) the consultation, through
data collection, of patients or/and their close relatives to
inform the assessment; and 3) the involvement of
patients in the dissemination of the HTA results.
For the first strategy, direct patient participation in the
HTA process, patient representatives will be involved in
a multidisciplinary working group specially established
by the HTA unit for this assessment. The local HTA
unit sets up a working group for every assessment it
undertakes, but for this project the working group will
be somewhat different from usual because of its supra-
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from several health regions. Patient representatives will
be added to this working group to offer their perspective
and their concrete experience as beneficiaries of the
technologies assessed. They will be recruited through
mental health and/or geriatric patients’ associations. For
the selection and supervision of these representatives,
we will draw on the experience of other HTA agencies
such as the National Institute for Health and Clinical
Excellence (NICE) and the National Health Service
(NHS) of the United Kingdom (INVOLVE, a national
advisory group for promoting public involvement in
NHS, public health and social care research) [25].
As for the second strategy, the consultation of patients
(or their close relatives) through primary data collection
will be conducted according to methods reported in the
literature on similar subjects [2,15,16,26,27]. We plan to
conduct about six (6) focus groups involving patients
and/or their close relatives. These focus groups will
encourage participants to discuss their experiences and
perceptions of alternatives to isolation and restraint.
The third strategy, involving patients in the dissemina-
tion and communication of the HTA results, will be
achieved in close collaboration with mental health and/
or geriatric patients’ associations involved in the HTA
project. We will draw on the experience of the NHS
Centre for Reviews and Dissemination in the United
Kingdom [28] for the production of written material sui-
table for members of these associations. The focus
groups will be consulted to make sure that the results
presented are accessible and useful to patients. The pro-
ject team researchers will collaborate with representa-
tives of target groups who have experience preparing
materials appropriate for communicating the results of
the assessment.
Patient representatives will also be asked to play the
role of ambassadors in “translating” the recommenda-
tions in the final HTA report so they can be transmitted
back to their associations and to the various mental
health and geriatric forums.
To improve our chances for successful interventions,
our approach will be based on the best scientific evi-
dence available about effective strategies for patient
involvement [13] and on the reference framework we
developed in collaboration with HTA producers and
HTA users [29].
Objectives 3 and 4
Evaluation of the process and impact of patient
involvement
The strategies used in this project must be evaluated to
establish their practicability and to provide evidence-
based data that will inform future strategies for invol-
ving patients in HTA [30]. As this study is likely to
influence practices in HTA, evaluation of the effective-
ness of our strategies will focus particularly on how the
patient involvement process is set up and subsequently
followed up, taking the views of all the different partici-
pants into account. We will also evaluate the impact of
our patient involvement strategies on the recommenda-
tions arising from the HTA, and evaluate patient under-
standing of the ethical and social issues relating to the
HTA.
We will base our evaluation of strategies on two sets
of criteria, those related to the process and those asso-
ciated with results and impacts. We will develop our
evaluation plan from the model proposed by Rowe [31]
that identifies nine criteria for assessing patient involve-
ment: five related to the effective construction and
implementation of a procedure (representativeness,
independence, early involvement, influence or impact on
decision making, and transparency) and four related to
process (accessibility of resources, task definition, exer-
cise of structured decision making, and cost-effective-
ness). However, a recent analysis by Rowe and
collaborators [14] of these criteria showed that although
they have a certain validity, they are not exhaustive nor
necessarily appropriate for all involvement activities or
all contexts. We will consequently use additional cri-
teria, some based on information we gathered during
interviews with various actors in HTA in Quebec [32]
and others that we identified from the literature on
patient and public participation.
The choice of outcome indicators, methods and analy-
sis strategies will be based on discussions with research-
ers and policy makers, an approach recognized as being
the most effective for knowledge translation [33,34]. The
research team will observe and evaluate the process and
results of the patient involvement strategies at each
stage of the project. The evaluation will be participatory
[35-38], which means that it will involve stakeholders at
each step of the evaluation (planning, design, data col-
lection and analysis, identification of findings, conclu-
sions, recommendations and dissemination of results).
At the beginning of the project a workshop will be
conducted with knowledge users and team researchers
to reach a consensus on the objectives and evaluation
questions. The data collection methods, the outcome
indicators, the data analysis plan, and the roles and
responsibilities of each team member will also be dis-
cussed. This collaborative approach is likely to increase
our success in strategy implementation, as the results
will relate directly to the challenges knowledge users
face and will address their practical needs. They will
thus be more likely to follow the recommendations
when making decisions [39].
The evaluation of involvement strategies will be based
on a mixed-method approach. Semi-structured interviews
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producers, and healthcare managers) will be held after
each phase of the project to identify the benefits and draw-
backs of each strategy, the factors that eased or compli-
cated its implementation, as well as how the strategy
influenced the HTA process, the recommendations, and
the perceptions of the various stakeholders. The evaluation
will also address the questions of time required, human
and material resources needed, and associated costs. This
will provide data for knowledge users interested in imple-
menting similar strategies. The evaluation will also focus
o nt h ep o s s i b i l i t yo fu s i n gt h et e s t e ds t r a t e g i e si no t h e r
HTA projects. The proposed approach is thus in keeping
with the knowledge translation cycle [40] in that the
knowledge produced and its evaluation within one context
will serve as a basis for developing interventions in other
contexts aiming at greater involvement of patients in
HTA.
Knowledge translation activities
The two elements most often associated with the useful-
ness of knowledge emerging from research findings in
decision making are the timeliness of the data and the
ongoing relationships between researchers and policy
makers [41]. Our approach to knowledge translation
(KT) is therefore based on these two keys elements.
First, the project answers a need expressed by policy
makers and HTA producers to move towards greater
involvement of patients in HTA activities. Second, the
close collaboration between researchers and knowledge
users in the team, which began with a previous project
and has been nourished by many exchanges since, will
continue throughout this project. Thus the participatory
approach [41] characterizing all stages of this research
project will promote mutual ownership of the research
results.
To facilitate the translation of our results we will
organize presentations in institutions involved in HTA
in the RUIS-UL. Presentations will also be offered to a
wider audience (such as the Ministry of Health and
Social Services) so that they can validate our process
and results and we can assess their applicability to other
organizations interested in HTA. These presentations
will form an integral part of the regular training activ-
ities of these organizations. To ensure their effective-
ness, we will target key messages identified during
workshops we previously conducted with policy makers
and patients to the specific audiences (managers, health
professionals, HTA producers and patients). The presen-
tations could also be made by knowledge users belong-
ing to the team or by patient representatives or
researchers, depending on the target audience. Thus, an
interactive process of knowledge translation will pro-
mote participation of targeted knowledge users (44, 45).
Towards the end of the project, we will organize a pro-
vincial meeting for representatives of the main HTA
producers and users groups (policy makers, managers,
HTA producers, health professionals and associations of
patients).
Discussion
A previous systematic review found little evidence about
effective strategies to involve patient in HTA [13]. In
the field of clinical practice guidelines, a systematic
review found that patient and public involvement was
more frequent in mental health [42]. This project repre-
sents a unique opportunity for policy makers and
researchers to work toward a common goal to test dif-
ferent forms of patient involvement in HTA and to eval-
uate them in order to produce useful knowledge
regarding the implementation of patient involvement
strategies in HTA and their possible effects and impacts.
By creating links between research and practice, this
project will establish a good balance between the inter-
ests and the expertise of researchers and those of knowl-
edge users. The knowledge users involved are already
working with researchers on the team; our collaborative
approach will ensure a common understanding of the
project’s objectives, activities and results [33,34]. This
will facilitate the translation of knowledge that is tai-
lored to the local context and to the specific reality of
knowledge users.
Since this study meets the needs expressed by knowl-
edge users belonging to the team and their partners in
the RUIS-UL, the knowledge produced will be directly
useful to guide practice in terms of patient involvement
in HTA activities. In addition to answering a real need
among decision makers and HTA knowledge users, this
project will not only contribute to the advancement of
knowledge about patient involvement strategies for
HTA, but it will also foster a greater involvement of
patients themselves in the field.
Ethical considerations
Interviewees and participants in the focus groups will be
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Additional material
Additional file 1: Appendix 1. Activities involving patients in phases of
the assessment process in local HTA and levels of patient involvement.
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